Sarah Smith

Sarah Smith is Co-founder and Chief Product Officer at Bodyport, a digital health company dedicated to improving the management of heart failure through novel medical devices, predictive algorithms, and virtual care. She leads the development of Bodyport’s FDA-cleared Cardiac Scale and virtual care software platform.

Previously, Sarah co-founded Atreo Medical to develop resuscitation technologies aimed at improving survival following cardiac arrest. Following Atreo’s acquisition by Medtronic, she joined the company’s Physio-Control division to lead integration efforts and bring the TrueCPR product to market. Sarah holds a degree in biomedical and electrical engineering from McMaster University in Hamilton, Canada.